Studies on prevalence of infection with Trichomonas tenax identified by molecular techniques - in respect to oral health of patients with various systemic disease requiring immunosuppressive therapy

• Autorzy: Dybicz M. , Perkowski K. , Sedzikowska A. , Baltaza W. , Chomicz L.
• Języki publikacji: EN

Abstrakty

EN

Trichomonas tenax, cosmopolitan flagellate inhabiting human oral cavity, is the etiological agent of oral trichomonosis associated with gingival and periodontium deterioration. Purpose of this studies was to investigate the prevalence of infection with Trichomonas tenax identified by molecular techniques amplifying the region of ITS1-5.8S rRNA-ITS2 specific for T. tenax. The study included 498 persons: diabetic, renal transplant, rheumatoid arthritis patients and the control group. Prevalence of T. tenax in oral cavity was 10.2% in control group, 14.1% in diabetics, 12.0% in renal transplant patients and 14.0% in rheumatoid arthritis patients. Comparative assessment of results showed symptoms of gingiva and periodontium deteriorations, at varying intensity in patients with various systemic diseases; higher prevalence of the trichomonad infection was revealed in adults in all groups. Simultaneously, renal transplantation, diabetes, rheumatoid arthritis and related therapy do not affect T. tenax incidences and no increased risk of the infection has been observed in the patients; the permanent medication used due to main disease should be taken into consideration as likely inhibitory factor.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2018
• Tom: 64
• Numer: 3
• Opis fizyczny: p.193-197,ref.

Twórcy

autor

Dybicz M.

• Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland

autor

Perkowski K.

• Department of Orthodontics, Medical University of Warsaw, Nowogrodzka 59, 02-005 Warsaw, Poland

autor

Sedzikowska A.

• Chair and Department of General Biology and Parasitology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland

autor

Baltaza W.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland

autor

Chomicz L.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland

Bibliografia

• [1] Kurnatowska A.J., Dudko A., Kurnatowski P. 2004. Inwazja Trichomonas tenax u pacjentów z chorobami przyzębia [Invasion of Trichomonas tenax in patients with periodontal diseases]. Wiadomości Parazytologiczne 50: 397-403 (in Polish with summary in English).
• [2] Duboucher C., Farto-Bensasson F., Chéron M, Peltier J.Y., Beaufils F, Périé G. 2000. Lymph node infection by Trichomonas tenax: report of a case with coinfection by Mycobacterium tuberculosis. Human Pathology 31: 1317-1321. doi:10.1053/hupa.2000.18502
• [3] Duboucher C., Mogenet M., Périé G. 1991. Salivary trichomoniasis. A case report of infestation of a submaxillary gland by Trichomonas tenax. Archives of Pathology and Laboratory Medicine 119: 277-279.
• [4] Shiota T., Arizono N., Morimoto T., Shimatsu A., Nakao K. 1998. Trichomonas tenax empyema in an immunocompromised patient with advanced cancer. Parasite 5: 375-377.
• [5] Stratakis D.F., Lang S.M., Eichenlaub S. 1999. Pulmonary trichomoniasis: diagnosis based on identification of irritation in bronchoalveolar lavage. Pneumologie 53: 617-619.
• [6] Mallat H., Podglajen I., Lavarde V., Mainardi J.L., Frappier J., Cornet M. 2004. Molecular characterization of Trichomonas tenax causing pulmonary infection. Journal of Clinical Microbiology 42: 3886-3887. doi:10.1128/JCM.42.8.3886-3887.2004
• [7] Bellanger A.P., Cabaret O., Costa J.M., Foulet F., Bretagne S., Botterel F. 2008. Two unusual occurrences of trichomoniasis: rapid species identification by PCR. Journal of Clinical Microbiology 46: 3159-3161. doi:10.1128/JCM.00322-08
• [8] Lewis K.L., Doherty D.E., Ribes J., Seabolt J.P., Bensadoun E.S. 2003. Empyema caused by Trichomonas. Chest 123: 291-292. doi:10.1378/chest.123.1.291
• [9] Mahmoud M.S., Rahman G.A. 2004. Pulmonary trichomoniasis: improved diagnosis by using polymerase chain reaction targeting Trichomonas tenax 18S rRNA gene in sputum specimens. Journal of the Egyptian Society of Parasitology 34: 197-211.
• [10] Leterrier M., Morio F., Renard B.T., Poirier A.S., Miegeville M., Chambreuil G. 2012. Trichomonads in pleural effusion: case report, literature review and utility of PCR for species identification. New Microbiologica 35: 83-87.
• [11] Dimasuay K.G.B., Rivera W.L. 2014. First report of Trichomonas tenax infections in the Philippines. Parasitology International 63: 400-402. doi:10.1016/j.parint.2013.12.015
• [12] Krvavac S. 1998. Trichomoniasis of the breast diseased by fibrocystic mastopathy: pathogenic rather than saprophytic relationship (Trichomonas in fibrocystic mastopathy process). Medical Archives 52: 143-145.
• [13] Jakobsen E.B., Friis-Møller A., Friis J. 1987. Trichomonas species in a subhepatic abscess. European Journal of Clinical Microbiology and Infectious Diseases 6: 296-297.
• [14] Cielecka D., Chomicz L., Piekarczyk J., Walski M., Zawadzki P.J., Bednarczyk A., Szybińska D. 2000. Oral cavity condition and the occurrence of parasitic protozoans in patients with genetic diseases. Acta Parasitologica 45: 107-112.
• [15] Chomicz L., Szubińska D., Piekarczyk J., Wojtowicz A., Piekarczyk B., Starościak B., Fiedor P. 2004. Występowanie subklinicznych zakażeń jamy ustnej u pacjentów z cukrzycą insulinozależną [Occurrence of oral subclinical infections in insulin treated diabetics]. Wiadomości Parazytologiczne 50: 177-180 (in Polish with summary in English).
• [16] Mehr A.K., Zarandi A., Anush K. 2015. Prevalence of oral Trichomonas tenax in periodontal lesions of Down syndrome in Tabriz, Iran. Journal of Clinical Diagnostic Research 9: ZC88-90. doi:10.7860/JCDR/2015/14725.6238
• [17] Chomicz L., Piekarczyk J., Starościak B., Fiedor P., Piekarczyk B., Wojtowicz A., Szubińska D., Świderski Z., Rebandel H. 2001. Host – protozoansbacteria – fungi interrelations in the mouths of patients with systemic illnesses. Wiadomości Parazytolo giczne 47: 559-563.
• [18] Chomicz L., Piekarczyk J., Fiedor P., Starościak B.J., Szubińska D., Wojtowicz A. 2002. Screening evaluation of oral cavity microorganisms in dialyzed and kidney allograft recipients under chronic immunosuppression. Transplantation Proceedings 34: 675-676.
• [19] Turkowicz M., Tomaszewska D., Cielecka D. 2004. Diagnostyka molekularna rzęsistków jamy ustnej u pacjentów z HIV [Molecular diagnosis of oral cavity trichomonads in HIV patients]. Wiadomości Parazytologiczne 47: 181-186 (in Polish with summary in English).
• [20] Grytner-Zięcina B., Jaworski J., Cielecka D., Gierczak A., Turkowicz M. 2002. Występowanie rzęsistka policzkowego Trichomonas tenax w jamie ustnej pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 3: 141-145 (in Polish).
• [21] Grzegorczyk-Jaźwińska A., Cielecka D., Juskowa J., Borakowska-Siennicka M., Gierczak A., Ołdakowska-Jedynak U., Turkowicz M. 2001. Występowanie Trichomonas tenax i stan jamy ustnej u pacjentów po przeszczepieniu nerki. Nowa Stomatologia 4: 43-45 (in Polish).
• [22] Bózner P., Demeš P. 1991. Degradation of collagen types I, III, IV and V by extracellular proteinases of an oral flagellate Trichomonas tenax. Archives of Oral Biology 36: 765-770.
• [23] Segovic S., Buntak-Kobler D., Galic N., Katunaric M. 1998. Trichomonas tenax proteolytic activity. Collegium Antropologicum 22: 45-49.
• [24] Nagao E., Yamamoto A., Igarashi T. 2000. Two distinct hemolysins in Trichomonas tenax ATCC 30207. Oral Microbiology and Immunology 15: 355-359.
• [25] El Sibaei M.M., Abdel-Fattah N.S., Ahmed S.A., Abou-Seri H.M. 2012. Growth kinetics, antigen profiling, and proteinase activity of Egyptian Trichomonas tenax isolates derived from patients having oral infections. Experimental Parasitology 130: 416-422. doi:10.1016/j.exppara.2012.01.018.
• [26] Chappell L.H., Wastling J.M. 1992. Cyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant. Parasitology 105: 25-40.
• [27] Bell A., Roberts H.C., Chappell L.H. 1996. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. General Pharmacology 27: 963-971.
• [28] Azouzi S., Morandat S., El Kirat K. 2011. The potent antimalarial peptide cyclosporin A induces the aggregation and permeabilization of sphingomyelinrich membranes. Langmuir 27: 9465-9472. doi:10.1021/la201040c
• [29] Marty M., Lemaitre M., Kémoun P., Morrier J.J., Monsarrat P. 2017. Trichomonas tenax and periodontal diseases: a concise review. Parasitology 144: 1417-1425. doi:10.1017/S0031182017000701
• [30] Rashidi Maybodi F., Haerian Ardakani A., Fattahi Bafghi A., Haerian Ardakani A., Zafarbakhsh A. 2016. The effect of nonsurgical periodontal therapy on Trichomonas tenax and Entamoeba gingivalis in patients with chronic periodontitis. Journal of Dental 17: 171-176.
• [31] Yazar S., Çetinkaya Ü., Hamamcì B., Alkan A., Şişman Y., Esen Ç., Kolay M. 2016. Investigation of Entamoeba gingivalis and Trichomonas tenax in periodontitis or gingivitis patients in Kayseri. Turkiye Parazitology Dergisi 40: 17-21. doi:10.5152/tpd.2016.4351

Identyfikatory

DOI

10.17420/ap6403.151